Biotech Bubble Watch 2014
A correction could be in the offing
This article is for subscribers only.
With valuations at historic highs, the industry’s bull run is looking frothy. Investors should brace for a correction, though not a 2000-like bust.
With valuations at historic highs, the industry’s bull run is looking frothy. Investors should brace for a correction, though not a 2000-like bust.